REFERENCES

1. Liangpunsakul S, Clinical characteristics and mortality of hospitalized alcoholic patients in the united states. J.Clin Gastroenterol 2011 (45): 714 – 719.
2. Gao B, Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 2011 (141): 1572 – 1585.
3. Harinasuta U, Chomet B, Ishak K, Zimmerman HJ. Steatonecrosis-Mallory body type. Medicine (Baltimore) 1967 (46): 141 – 162.
4. Botros M, Sikaris KA. The Deritis ratio: The test of time. 2013 (34): 117 – 130.
5. Butt AR, Ahmed S, Haider N, Ditta A, Khokar AS, Khokhar MS, Tayyab M. Evaluation of AST/ALT ratio in patients with liver disease Pak J Med Sci 2001 (17): 225 -228.
6. De Ritis F, Coltorti M, Giusti G. An enzymatic test for the diagnosis of viral hepatitis: the transaminase serum activities. Clin Chim Acta 1957 (2): 70 – 74.
7. Deritis F, Giusti G, Piccinio F, Cacciatore L. Biochemical laboratory tests in viral hepatitis and other hepatic diseases. Bull world Health organ 1965 (32): 59 – 72.
8. Vassault A et.al; Protocole de validation de techniques, Ann Biol Clin 1986 (44): 686.
9. Cohen JA, Kaplan MM. The SGOT/SGPT ratio – an indicator of alcoholic liver disease. Dig Dis Sci 1979 (24): 835 – 838.
10. Correia JP, Alves PS, Camilo EA. SGOT-SGPT ratios. Dig Dis Sci 1981 (26): 284
11. Alves PS, Camilo EA, Correia JP. The SGOT/SGPT ratio in alcoholic liver disease. Acta Med Port 198 (3): 255 – 260.
12. Takahashi A, sekiya C, Yazaki Y, Ono M, Sato H, Hasebe C, et.al. [Hepatic GOT and GPT activities in patients with various liver diseases-especially alcoholic liver disease]. Hokkaido Igaku Zasshi 1986 (61): 431-436.
13. Sharpe PC. Biochemical monitoring and alcohol abuse and abstinence. Ann Clin Biochem 2001 (38): 652 – 654.
14. Hietala J, Puukkaa K, Koivisto H, Anntila P, Niemala O. Serum gamma-glutamyl transferase in alcoholics, moderate drinkers and abstainers: effect on gt reference intervals at population level. Alcohol Alcohol 2005 (40): 511 – 54.
15. Rosman AS, Lieber CS. Diagnostic utility of laboratory tests in alcoholic liver disease. Clin Chem 1994 (40): 1641 – 1651.
16. Hourigan KJ, Bowling FG. Alcoholic liver disease: a clinical series in an Australian private practice. J. Gasstroenterol Hepatol 2001 (16): 138-1143.
17. Nyblom H, Berggren U, Balldin J, Olsson R. High AST/ALT ratio may indicate advanced alcoholic liver disease rather than heavy drinking. Alcohol Alcohol 2004 (39): 336-339.
18. Matloff DS, Selinger MJ, Kaplan MM. Hepatic transaminase activity in alcoholic liver disease. Gastroenterology 1980 (78): 1389-1392.
19. Diehl AM, Potter J, Boitnott J, Van Duyn MA, Herlong HF, Mezey E. Relationship between pyridoxal 5’- phosphate deficiency and aminotransferase levels in alcoholic hepatitis. Gastroenterology 1984 (86): 632-636.
20. Nalpas B, Vassault A, Le Guillou A, Lessgourgues B, Ferry N, Lacour B, et.al. Serum activity of mitochondrial aspartate transaminase: a sensitive marker of alcoholism with or without alcoholic hepatitis. Hepatology 1984 (4): 893 – 896.
21. Rej R. Aspartate aminotransferase activity and isoenzyme proportions in human liver tissues. Clin Chem 1978 (24) 1971-1979.
22. Ishii H, Okuno F, Shiegata Y, Tsuchiya M. Enhanced serum glutamate oxaloacetic transaminase activity of mitochondrial origin in chronic alcoholics. Curr Alcohol 1979 (5): 10-108.
23. Nalpas B, Vassault A, Charpin S, Lacour B, Berthelot P. Serum mitochondrial aspartate aminotransferase as a marker of chronic alcoholism: diagnostic value and interpretation in a liver unit. Hepatology 1984 (4): 893-896.
24. Okuno F, Ishii H, Kashiwazaki K, Takagi S, Shigeta Y, Arai M, et.al. Increase in mitochondrial GOT (m-GOT) activity after chronic alcohol consumption: clinical and experimental observations. Alcohol 1988 (5): 49-53.
25. Pujar S, Kashinakunthi SV, Kallaganad GS, Dambal A, Doddamani GV. Evaluation of Deritis in Alcoholic and non-alcoholic liver diseases – A case control study 2010 (4): 2463-2466.